Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilson Tang

Showing results (131-140 of 1,043) with videos related to

Pageof 105
Sort By:
European Journal of Heart Failure|April 3, 2020
A means to an end: the promise of tracking natriuresis with diuretic therapyRobert A Montgomery, W H Wilson Tang
Circulation|March 15, 2017
The Gut Microbiome and Its Role in Cardiovascular DiseasesW H Wilson Tang, Stanley L Hazen
Journal of the American College of Cardiology|January 11, 2011
Polyunsaturated fatty acids in heart failure: should we give more and give earlier?W H Wilson Tang, Michael A Samara
Journal of Cardiac Failure|August 18, 2005
The difficult task of evaluating how to monitor patients with heart failureW H Wilson Tang, Gary S Francis
Journal of the American College of Cardiology|December 6, 2005
The year in heart failureW H Wilson Tang, Gary S Francis
Journal of the American College of Cardiology|December 24, 2016
Reply: Trimethylamine N-Oxide in Seafood: Rotten or Forgotten?W H Wilson Tang, Stanley L Hazen
Nature Reviews. Cardiology|January 18, 2017
Atherosclerosis in 2016: Advances in new therapeutic targets for atherosclerosisW H Wilson Tang, Stanley L Hazen
Translational Research : the Journal of Laboratory and Clinical Medicine|August 5, 2016
Microbiome, trimethylamine N-oxide, and cardiometabolic diseaseW H Wilson Tang, Stanley L Hazen
European Heart Journal|October 2, 2007
Exploring new drugs for heart failure: the case of urocortinW H Wilson Tang, Gary S Francis
JAMA|April 29, 2004
Vasopressin receptor antagonists: will the "vaptans" fulfill their promise?Gary S Francis, W H Wilson Tang
Pageof 105

Showing results (131-140 of 1,043) with videos related to

Sort By:
Pageof 105
European Journal of Heart Failure|April 3, 2020
A means to an end: the promise of tracking natriuresis with diuretic therapyRobert A Montgomery, W H Wilson Tang
Circulation|March 15, 2017
The Gut Microbiome and Its Role in Cardiovascular DiseasesW H Wilson Tang, Stanley L Hazen
Journal of the American College of Cardiology|January 11, 2011
Polyunsaturated fatty acids in heart failure: should we give more and give earlier?W H Wilson Tang, Michael A Samara
Journal of Cardiac Failure|August 18, 2005
The difficult task of evaluating how to monitor patients with heart failureW H Wilson Tang, Gary S Francis
Journal of the American College of Cardiology|December 6, 2005
The year in heart failureW H Wilson Tang, Gary S Francis
Journal of the American College of Cardiology|December 24, 2016
Reply: Trimethylamine N-Oxide in Seafood: Rotten or Forgotten?W H Wilson Tang, Stanley L Hazen
Nature Reviews. Cardiology|January 18, 2017
Atherosclerosis in 2016: Advances in new therapeutic targets for atherosclerosisW H Wilson Tang, Stanley L Hazen
Translational Research : the Journal of Laboratory and Clinical Medicine|August 5, 2016
Microbiome, trimethylamine N-oxide, and cardiometabolic diseaseW H Wilson Tang, Stanley L Hazen
European Heart Journal|October 2, 2007
Exploring new drugs for heart failure: the case of urocortinW H Wilson Tang, Gary S Francis
JAMA|April 29, 2004
Vasopressin receptor antagonists: will the "vaptans" fulfill their promise?Gary S Francis, W H Wilson Tang
Pageof 105